ITGR

Integer Holdings Corporation

$126.62

0.05%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.

Source: Yahoo Finance
AI summary

Price & performance

1M+0.2%
3M+25.5%
YTD+64.9%
1Y+99.9%
52-week range—
Beta0.80
Full chart and returns against a benchmark

Q-Score

63/ 100

Quality against peers; 50 is the peer median.

Growth52
Risk72
Performance58
Valuation61
Profitability60
Leverage52
Sentiment11
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$1.9B+8.0%
Net income$102.8M-14.3%
Net margin5.5%-1.4 pts
Historical fundamentals

Revenue exposure

47%of revenue from outside the US
United States53%
Rest of World25%
CR9%
Largest customer20%
Regions, segments, customers and suppliers

Valuation

ITGRIndustryP/E41.5129.61P/S2.363.49EV/EBITDA19.0018.38P/B2.493.39PEG2.152.15
Dividend yield0.00%
Every valuation metric

Earnings

Oct 29next report
EPS estimate$1.68
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate